These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 21733060)
21. Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187. Gedulin BR; Jodka CM; Herrmann K; Young AA Regul Pept; 2006 Dec; 137(3):121-7. PubMed ID: 16914214 [TBL] [Abstract][Full Text] [Related]
22. Amylin-mediated control of glycemia, energy balance, and cognition. Mietlicki-Baase EG Physiol Behav; 2016 Aug; 162():130-40. PubMed ID: 26922873 [TBL] [Abstract][Full Text] [Related]
23. Hypoglycemia attenuates acute amylin-induced reduction of food intake in male rats. Honegger M; Lutz TA; Boyle CN Physiol Behav; 2021 Aug; 237():113435. PubMed ID: 33933418 [TBL] [Abstract][Full Text] [Related]
24. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models. Clapper JR; Athanacio J; Wittmer C; Griffin PS; D'Souza L; Parkes DG; Roth JD Eur J Pharmacol; 2013 Jan; 698(1-3):292-8. PubMed ID: 23178527 [TBL] [Abstract][Full Text] [Related]
25. Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog. Gydesen S; Andreassen KV; Hjuler ST; Hellgren LI; Karsdal MA; Henriksen K Am J Physiol Endocrinol Metab; 2017 Nov; 313(5):E598-E607. PubMed ID: 28292761 [TBL] [Abstract][Full Text] [Related]
26. The Calcitonin Receptor Plays a Major Role in Glucose Regulation as a Function of Dual Amylin and Calcitonin Receptor Agonist Therapy. Larsen AT; Sonne N; Andreassen KV; Karsdal MA; Henriksen K J Pharmacol Exp Ther; 2020 Jul; 374(1):74-83. PubMed ID: 32317372 [TBL] [Abstract][Full Text] [Related]
27. KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration. Hjuler ST; Andreassen KV; Gydesen S; Karsdal MA; Henriksen K Eur J Pharmacol; 2015 Sep; 762():229-38. PubMed ID: 26027795 [TBL] [Abstract][Full Text] [Related]
28. Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Young AA; Gedulin B; Vine W; Percy A; Rink TJ Diabetologia; 1995 Jun; 38(6):642-8. PubMed ID: 7672483 [TBL] [Abstract][Full Text] [Related]
29. Effects of acute and chronic infusion of islet amyloid polypeptide on food intake in rats. Arnelo U; Blevins JE; Larsson J; Permert J; Westermark P; Reidelberger RD; Adrian TE Scand J Gastroenterol; 1996 Jan; 31(1):83-9. PubMed ID: 8927946 [TBL] [Abstract][Full Text] [Related]
30. Chronic infusion of the amylin antagonist AC 187 increases feeding in Zucker fa/fa rats but not in lean controls. Grabler V; Lutz TA Physiol Behav; 2004 May; 81(3):481-8. PubMed ID: 15135020 [TBL] [Abstract][Full Text] [Related]
32. Amylin receptor blockade stimulates food intake in rats. Reidelberger RD; Haver AC; Arnelo U; Smith DD; Schaffert CS; Permert J Am J Physiol Regul Integr Comp Physiol; 2004 Sep; 287(3):R568-74. PubMed ID: 15130879 [TBL] [Abstract][Full Text] [Related]
33. Role of amylin in nutrient intake - animal studies. Young A Diabet Med; 1997 Jun; 14 Suppl 2():S14-8. PubMed ID: 9212324 [TBL] [Abstract][Full Text] [Related]
34. Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat. Clementi G; Caruso A; Cutuli VM; de Bernardis E; Prato A; Amico-Roxas M Experientia; 1996 Jul; 52(7):677-9. PubMed ID: 8698109 [TBL] [Abstract][Full Text] [Related]
37. The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats. Lutz TA; Mollet A; Rushing PA; Riediger T; Scharrer E Int J Obes Relat Metab Disord; 2001 Jul; 25(7):1005-11. PubMed ID: 11443499 [TBL] [Abstract][Full Text] [Related]
39. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner. Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060 [TBL] [Abstract][Full Text] [Related]
40. Amylin is more potent and more effective than glucagon in raising plasma glucose concentration in fasted, anesthetized rats. Wang MW; Carlo P; Rink TJ; Young AA Biochem Biophys Res Commun; 1991 Dec; 181(3):1288-93. PubMed ID: 1764079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]